2024-10-25 - Analysis Report
## Johnson & Johnson (JNJ) Stock Analysis Report

**Company Overview:** Johnson & Johnson is a multinational pharmaceutical, medical device, and consumer packaged goods company.

**1. Performance Comparison with S&P 500 (VOO):**

* **Cumulative Return (JNJ):** 36.59%
* **Cumulative Return (VOO):** 135.48%
* **Lagging Behind:** JNJ has significantly lagged behind the S&P 500, with a cumulative return difference of **-98.89%**. 
* **Relative Lag:** This represents a position at the **5.74th percentile** of historical performance relative to the S&P 500.

**2. Recent Price Action:**

* **Closing Price:** 163.67 (Post-market: 163.65)
* **5-Day Moving Average:** 164.01
* **20-Day Moving Average:** 162.26
* **60-Day Moving Average:** 162.73

**3. Technical Indicators:**

* **RSI:** 61.51 (Neutral)
* **PPO:** 0.19 (Slight Bullish)
* **Delta_Previous_Relative_Divergence:** +0.4 (Short-term Upward Trend)
* **Expected Return:** 0.0% - This indicates a potential for long-term (2+ years) returns similar to the S&P 500.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-10-23 | 1.12 | 22.47 B$ |
| 2024-07-25 | 1.95 | 22.45 B$ |
| 2024-05-01 | 1.35 | 21.38 B$ |
| 2024-02-16 | 1.68 | 21.39 B$ |
| 2023-10-27 | 10.32 | 21.35 B$ |

* **Most Recent Earnings (2024-10-23):** The latest earnings report showed EPS of 1.12, which was slightly below analysts' expectations. 
* **Outlook:** Johnson & Johnson's diversified business model provides stability, but concerns remain regarding pharmaceutical competition, regulatory changes, and potential legal liabilities.

**5. News and Recent Issues:**

* **Recent Earnings News:**  [Insert a summary of any recent earnings news articles, such as Shacknews or other financial news outlets, that might have been published within the last 2 days.]
* **Recent Market Outlook:** [Insert a brief summary of recent market outlook for JNJ from sources like FINBOLD, emphasizing any key analyst opinions or performance highlights.] 

**6. Overall Analysis:**

JNJ currently lags behind the S&P 500 performance.  While its diversified business model provides stability, its recent earnings report suggests potential for moderate growth.  Technical indicators suggest a slight bullish bias, but its high RSI suggests that the stock may be nearing overbought territory. 

**7. Recommendations:**

* **Short-Term (1-3 months):**  Monitor the stock's price action and wait for a potential pullback or dip before considering a purchase.
* **Long-Term (2+ years):** Consider JNJ as a potential addition to a diversified portfolio for long-term growth, aiming for returns similar to the S&P 500.

**Disclaimer:** This analysis is intended for informational purposes only and should not be considered as investment advice. It is crucial to conduct your own research and consult with a qualified financial advisor before making any investment decisions. 
